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Aim and methods
a retrospective review of germline genetic testing (VHL,
RET and succinate dehydrogenase subunit genes SDHB,
SDHC and SDHD) and immunohistochemical staining
for SDHB in tumour tissue (SDHB-IHC), in patients
referred to the South Australian Familial Cancer Unit
with an adrenal phaeochromocytoma (PC) and/or para-
ganglioma (PGL).
Results
between January 1999 and May 2011, 24 probands were
referred to and assessed by our service. The clinical pre-
sentation and mutation pick up are presented in the
table. Tumour tissue was available from 20 probands
and SDHB-IHC was abnormal in all probands with an
SDH mutation (5/5; 100%), 0/1 with a VHL mutation
and 2/12 (16%) with no identified mutation (the 2 pro-
bands with abnormal SDHB-IHC both presented with
familial head & neck PGL). Tissue was unavailable for
testing in the remaining 4 patients; 3 with a RET muta-
tion and a MEN2 phenotype; 1 with an SDHD mutation
and familial head & neck PGL (SDH-IHC is pending in
her affected sister). Table 1.
Conclusion
our experience supports using SDHB-IHC as a tool to
triage genetic testing in patients with PC or PGL.
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Table 1
Phenotype No. Number with mutation identified
Total RET VHL SDHB SDHC SDHD
Apparently sporadic unilateral PC 10^ 1 - - 1* - -
Familial PC 11 -1- - -
PC & MEN2 features 33 3-- - -
Apparently sporadic head & neck PGL 42 --- 1 1
Familial head & neck PGL 31 --- - 1
Apparently sporadic malignant abdominal PGL 32 --2 - -
TOTAL 24 10 3 1 3 1 2
* presented with unilateral PC and developed a head and neck PGL 14 years after the PC
^ VHL and RET testing incomplete in 2 (complete testing will be presented at the meeting)
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